Koyfin Home > Directory > Health Care > Arbutus Biopharma Cp > Issuance of Common Stock

Arbutus Biopharma Cp Issuance of Common Stock Chart (ABUS)

Arbutus Biopharma Cp annual/quarterly Issuance of Common Stock from 2010 to 2018.
  • Arbutus Biopharma Cp Issuance of Common Stock for the quarter ending September 09, 2018 was $0m a 92.18% increase of 0m year over year
  • Arbutus Biopharma Cp Issuance of Common Stock for the last 12 months ending September 09, 2018 was $1m a 65.34% increase of 1m year over year
  • Arbutus Biopharma Cp Annual Issuance of Common Stock for 2017 was $0m a -40.62% decrease of 0m from 2016
  • Arbutus Biopharma Cp Annual Issuance of Common Stock for 2016 was $1m a -22,485.56% decrease of -143m from 2015
  • Arbutus Biopharma Cp Annual Issuance of Common Stock for 2015 was $144m a 54.99% increase of 79m from 2014
Other Cash Flow Metrics:
  • Arbutus Biopharma Cp Cash Flow from Operations for the quarter ending December 12, 2018 was $-17m a -16.70% increase of 3m year over year
  • Arbutus Biopharma Cp Levered Free Cash Flow (FCF) for the quarter ending December 12, 2018 was $-36m a 63.34% decrease of -23m year over year
  • Arbutus Biopharma Cp Total Revenue for the quarter ending December 12, 2018 was $2m a 12.06% increase of 0m year over year
View Chart On Koyfin

Quarterly ABUS Issuance of Common Stock Data

09/2018$0m
06/2018$1m
03/2018$0m
12/2017$0m
09/2017$0m
06/2017$0m
03/2017$0m
09/2016$0m
06/2016$0m
03/2016$0m

Annual ABUS Issuance of Common Stock Data

2017$0m
2016$1m
2015$144m
2014$65m
2013$35m
2012$4m
2011$4m
2010$0m
2009$0m